| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |